Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
08/2006
08/09/2006EP1687272A1 2-ethyl-4,6-dimethyl-phenyl-substituted spirocyclic tetramic acid derivatives
08/09/2006EP1687268A1 Benzylether amine compounds useful as ccr-5 antagonists
08/09/2006EP1687002A1 Fused heterocyclic compounds
08/09/2006EP1397361B1 Carboline derivatives as pdev inhibitors
08/09/2006EP1317451B1 Chemokine receptor binding heterocyclic compounds
08/09/2006EP1135135A4 Chk1 kinase inhibitors
08/09/2006EP0988301B1 Imidazolyl-cyclic acetals
08/09/2006CN1816553A Process for the preparation of furopyrroles
08/09/2006CN1268338C Oral administration of 6-hydroxy-oxymorphone for use as antalgesic
08/09/2006CN1268336C Pharmaceutical composition, dosage form, and method of epothilones for oral administration
08/08/2006US7087636 A 4,7-methano-1,2-benzisothiazol-3-one-1,1-dioxide derivatives, for treating cancer, immune modulation
08/08/2006US7087615 Antiinflammatory agents; antiarthritic agents
08/08/2006US7087614 Pyrimidine inhibitors of phosphodiesterase (PDE) 7
08/08/2006US7087603 Pyrazole compounds useful as protein kinase inhibitors
08/08/2006US7087601 Psychological disorders; anxiolytic agents; antidepressants; analgesics ; schizophrenia
08/08/2006US7087597 Pyrimidine 5-carboxamide compounds, process for producing the same and use thereof
08/03/2006WO2006080450A1 Igf-1r inhibitor
08/03/2006WO2006080439A1 Tricyclic compound
08/03/2006WO2006079644A1 Indolopyridines, benzofuranopyridines and benzothienopyridines
08/03/2006WO2006079637A1 Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders
08/03/2006WO2006079467A1 Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors
08/03/2006WO2006065479A3 Substituted phenols as active agents inhibiting vegf production
08/03/2006WO2006064355A3 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders
08/03/2006WO2006032893A3 Trityl derivatives for enhancing mass spectrometry
08/03/2006US20060173054 Treating Alzheimer's disease; e.g. 2',3',4',5,5',6,7,8,9,10-Decahydro-2-(5-(4-fluorophenyl)-1-methyl-pyrazol-3-yl)-5'-(2,2,2-trifluoroethyl)-spiro(6,9-methanobenzocyclooctene-11,3'-(1,2,5)thiadiazole)-1',1'-dioxide
08/03/2006US20060173044 Substituted propargylamines
08/03/2006US20060173034 Novel 4-anilinoquinoline-3-carboxamides
08/03/2006US20060173031 Therapeutic agent for schizophrenia
08/03/2006US20060173030 Antitumoral analogs of lamellarins
08/03/2006US20060173027 Spirocvclic piperidines as mch1 antagonists and uses thereof
08/03/2006US20060173026 8-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents
08/03/2006US20060173013 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity
08/03/2006US20060173003 4-Heteroarylamino-7-H(hetero)aryl-substituted, e.g., [6-(propane-2-sulfonyl)-pyridin-3-yl]-[7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl ]-amine hydrochloride; the compounds inhibit binding of vanilloid ligands to capsaicin receptors and are used to treat neuropathic pain
08/03/2006US20060172999 2-[(1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-phenyl-tetrahydropyran-4-yl]methyl-2-oxa-8-aza-spiro[4,5]decan-4-ol; neurokinin 1 (NK-1) receptor antagonists; antidepressant, anxiolytic, analgesic, antiinflammatory agent; migraine, emesis or postherpetic neuralgia
08/03/2006US20060172995 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
08/03/2006US20060172950 Hepatitis C virus inhibitors
08/03/2006CA2596527A1 Igf-1r inhibitors
08/03/2006CA2595605A1 Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors
08/03/2006CA2595247A1 Indolopyridines, benzofuranopyridines and benzothienopyridines
08/03/2006CA2595170A1 Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders
08/02/2006EP1685134A1 Novel chelidonine derivatives, methods for the production thereof, and use thereof for producing pharmaceutical agents
08/02/2006EP1685133A1 Manufacture of vitamin b6
08/02/2006EP1684754A1 Hmg-coa reductase inhibitors and method
08/02/2006EP1381614B1 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO¬2,3-f|QUINOXALINE
08/02/2006EP1212328B1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
08/02/2006EP1076057B1 Febrifugine and isofebrifugine and processes for the preparation of both
08/02/2006CN1812980A Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
08/02/2006CN1267438C antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7h-[1,4] dioxino [2,3-3] indole
08/02/2006CN1267434C Antidepressant (SSSRI) azaheterocyclymethyl derivatives of 7,8-dihydro-3H-6, 9-dioxa-1,3-diazacyclopenta[A] naphthalene
08/02/2006CN1267430C Triazole compounds with dopamine -D3-receptor affinity
08/01/2006US7084168 Indoline derivatives
08/01/2006US7084166 Such as 1,1-di-(N-benzyl-indol-3-yl)-1-butene; for drug resistant tumors
08/01/2006US7084158 Substituted propargylamines
08/01/2006US7084156 2-Aminoquinoline compounds
08/01/2006US7084155 Chemokine receptor binding heterocyclic compounds
08/01/2006US7084152 4-phenyl substituted tetrahydroisoquinolines therapeutic use thereof
08/01/2006US7084151 Urogenital disorders; dysmenorrhea; endometriosis; anticancer agents
08/01/2006US7084150 pain therapy, transdermal application
08/01/2006US7084139 Cardiovascular disorders; anticoagulants; antitumor, anticancer agents; Alzheimer's disease; Parkinson's disease
08/01/2006CA2276945C Tricyclic-substituted pyrazolyl benzenesulfonamides and pharmaceutical compositions thereof
07/2006
07/27/2006WO2006078865A2 Direct racemization of indole derivatives
07/27/2006WO2006078834A1 Novel heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors
07/27/2006WO2006078809A2 Method for the preparation of maytansinoid esters
07/27/2006WO2006078775A1 Imidazole and benzimidazole derivatives useful as histamine h3 antagonists
07/27/2006WO2006078368A1 Methods for the production of ansamitocins
07/27/2006WO2006077013A1 Tetrahydrofurane derivatives for use as inhibitors of matrix metalloproteinases
07/27/2006WO2006050128A3 Heterocyclical chromophore architectures
07/27/2006WO2006027344A3 3-oxa-10-aza-phenanthrenes as pde4 or pde3/4 inhibitors
07/27/2006WO2006014647A3 Cyclic n-hydroxy imides as inhibitors of flap endonuclease and uses thereof
07/27/2006WO2005020894A3 Rifamycin analogs and uses thereof
07/27/2006US20060167259 Direct racemization of indole derivatives
07/27/2006US20060167245 Method for the preparation of maytansinoid esters
07/27/2006US20060167039 Nicotinic alpha-7 receptor ligands and preparation and uses thereof
07/27/2006US20060167033 viral infections; lung tumor and gastric cancer; 7-2-(2-aminophenyldithio)phenyliminomethylcamptothecin
07/27/2006US20060167000 veterinary medicine; neurodegenerative diseases; Alzheimers's Disease
07/27/2006US20060166979 for prophylaxis and treatment of atrial and ventricular arrhythmias
07/27/2006US20060166977 Antibacterial agents
07/27/2006US20060166964 Indoles fused to a five- to twelve-membered ring that is in turn fused to a five- or six-membered aromatic ring;, e.g., 13-cyclohexyl-N-(cyclopropylsulfonyl)-3-methoxy-6-(4-morpholinylcarbonyl)-7H-indolo[2,1-a][2]benzazepine-10-carboxamide
07/27/2006US20060166829 N-Heterocycl phenyl-substituted cyclic ketoenols
07/27/2006DE102005002500A1 Tetrahydrofuranderivate als Inhibitoren von Matrix-Metalloproteinasen Tetrahydrofuran derivatives as inhibitors of matrix metalloproteinases
07/27/2006CA2834033A1 Methods for the production of ansamitocins
07/27/2006CA2601357A1 Tetrahydrofurane derivatives for use as inhibitors of matrix metalloproteinases
07/27/2006CA2595477A1 Novel heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors
07/27/2006CA2595157A1 Imidazole and benzimidazole derivatives useful as histamine h3 antagonists
07/27/2006CA2595024A1 Methods for the production of ansamitocins
07/26/2006EP1683803A1 Water soluble prodrugs of hindered alcohols or phenols
07/26/2006EP1683794A1 Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
07/26/2006EP1683056A2 Method for identifying inhibitors using a homology model of polo-like kinase 1
07/26/2006EP1682554A1 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
07/26/2006EP1682552A1 Tocopherol-modified therapeutic drug compounds
07/26/2006EP1682543A1 Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
07/26/2006EP1682541A1 Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
07/26/2006EP1682502A1 Sulfonyltetrahydro-3h-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands
07/26/2006EP1682138A2 Heterocyclic inhibitors of mek and methods of use thereof
07/26/2006EP1534705B1 Process for preparing zolmitriptan compounds
07/26/2006CN1809574A Quinoline 3-amino chroman derivatives
07/26/2006CN1809561A Phenylacetamides and their use as glucokinase modulators
07/26/2006CN1809560A Thiazolylpiperidine derivatives as mtp inhibitors
07/26/2006CN1809538A Cis-2,4,5-triaryl-imidazolines
07/26/2006CN1809349A 5-oxo and 5-thio derivatives of 5h-indeno'1,2-bipyridine with adenosine A2A receptor binding and phosphodiesterase inhibiting activity for the treatment of neurodegenerative disorders and inflammation